MAPK1 and depressive symptom measurement: GSK3B may be involved in the development of depression by inhibiting Erk-CREB-BDNF signaling [99], and PI3K/Akt/mTOR/GSK3B signaling may be the mechanism underlying the rapid antidepressant effects [100].